Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Singapore’s national AI program has moved its Sea-Lion large language model off Meta’s model ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

General Atomics Aeronautical Systems (GA-ASI) is showcasing its candidate for the US Air Force’s Collaborative Combat Aircraft (CCA) requirement for the first time in the Middle East. A full-scale ...

After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...

If we assume for a moment that Tesla’s recent sales declines are entirely due to faulty management, specifically caused by people with the job title “program manager,” then Tesla is well in its way to ...

(Reuters) -Tesla's best-selling Model Y's program manager, Emmanuel Lamacchia, announced his departure on Sunday after nearly eight years, marking another high-profile exit from Elon Musk's electric ...

The moves to fire or sideline generals and admirals are without precedent in recent decades and have rattled the top brass. Credit...Photographs by Andrew Caballero-Reynolds/Agence France-Presse — ...

Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...